{"DataElement":{"publicId":"3467274","version":"2","preferredName":"Predictive Biomarker Name","preferredDefinition":"Text name of a measurable and quantifiable biological parameter which serve as an index for health and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.","longName":"PRED_BIOM_NM","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3467213","version":"1","preferredName":"Disease Predictive Factor Biomarker Analysis","preferredDefinition":"Characteristics and conditions that have a bearing on the likelihood of a person developing a disease or disorder._Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc_Analysis; examination and interpretation.","longName":"PRED_BIO_ANLY","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3467211","version":"1","preferredName":"Disease Predictive Factor Biomarker","preferredDefinition":"Characteristics and conditions that have a bearing on the likelihood of a person developing a disease or disorder.:Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc","longName":"C28282:C16342","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Predictive Factor","conceptCode":"C28282","definition":"Characteristics and conditions that have a bearing on the likelihood of a person developing a disease or disorder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C15A0AFA-4569-A132-E040-BB89AD435F09","latestVersionIndicator":"Yes","beginDate":"2012-05-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-05-31","modifiedBy":"ONEDATA","dateModified":"2012-05-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2261838","version":"1","preferredName":"Analysis","preferredDefinition":"Analysis; examination and interpretation.","longName":"C25391","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Analysis","conceptCode":"C25391","definition":"Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FBB87D79-96F9-0549-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-13","modifiedBy":"ONEDATA","dateModified":"2005-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C15A0AFA-4577-A132-E040-BB89AD435F09","latestVersionIndicator":"Yes","beginDate":"2012-05-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-05-31","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3467215","version":"2","preferredName":"Predictive Factor Biomarker Name","preferredDefinition":"Characteristics and conditions that have a bearing on the likelihood of a person developing a disease or disorder._Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc_The words or language units by which a thing is known.","longName":"PRED_BIO_NM","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"80","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Both of the above (EGFR TK Mutation/EML4-ALK fusion arrangement)","valueDescription":"Both EGFR TK Mutation and EML4-ALK fusion arrangement","ValueMeaning":{"publicId":"3653017","version":"1","preferredName":"Both EGFR TK Mutation and EML4-ALK fusion arrangement","longName":"3653017","preferredDefinition":"Epidermal growth factor receptor. The protein found on the surface of some cells and to which epidermal growth factor binds, causing the cells to divide. It is found at abnormally high levels on the surface of many types of cancer cells, so these cells may divide excessively in the presence of epidermal growth factor.: Kinases that phosphorylate protein tyrosine residues. These kinases play major roles in mitogenic signalling, and can be divided into two subfamilies: receptor tyrosine kinases, that have an extracellular ligand-binding domain, a single transmembrane domain, and an intracellular tyrosine kinase domain; and nonreceptor tyrosine kinases, which are soluble, cytoplasmic kinases. (Dictionary of Cell and Molecular Biology Online): A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically.: Echinoderm microtubule-associated protein like 4 (981 aa, ~109 kDa) is encoded by the human EML4 gene. This protein may play a role in the modification of microtubule assembly dynamics.: The 2;5 chromosomal translocation is frequently associated with anaplastic large cell lymphomas (ALCLs). The translocation creates a fusion gene consisting of the ALK (anaplastic lymphoma kinase) gene and the nucleophosmin (NPM) gene: the 3' half of ALK, derived from chromosome 2, is fused to the 5' portion of NPM from chromosome 5. A recent study shows that the product of the NPM-ALK fusion gene is oncogenic. The deduced amino acid sequences reveal that ALK is a novel receptor protein-tyrosine kinase having a putative transmembrane domain and an extracellular domain. These sequences are absent in the product of the transforming NPM-ALK gene.: Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene p","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epidermal Growth Factor Receptor","conceptCode":"C17068","definition":"Epidermal growth factor receptor (1210 aa, ~134 kDa) is encoded by the human EGFR gene. This protein plays a role in cell-cell adhesion, cell migration, cell proliferation and signal transduction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Protein Tyrosine Kinase","conceptCode":"C17020","definition":"Kinases that phosphorylate protein tyrosine residues. These kinases play major roles in mitogenic signalling, and can be divided into two subfamilies: receptor tyrosine kinases, that have an extracellular ligand-binding domain, a single transmembrane domain, and an intracellular tyrosine kinase domain; and nonreceptor tyrosine kinases, which are soluble, cytoplasmic kinases. (Dictionary of Cell and Molecular Biology Online)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Echinoderm Microtubule-Associated Protein-Like 4","conceptCode":"C71005","definition":"Echinoderm microtubule-associated protein-like 4 (981 aa, ~109 kDa) is encoded by the human EML4 gene. This protein may play a role in the modification of microtubule assembly dynamics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"ALK Tyrosine Kinase Receptor","conceptCode":"C27032","definition":"ALK tyrosine kinase receptor (1620 aa, ~176 kDa) is encoded by the human ALK gene. This protein is involved in ligand binding, tyrosine phosphorylation and signal transduction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D37CA4FD-40DA-95E4-E040-BB89AD43110F","latestVersionIndicator":"Yes","beginDate":"2013-01-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-01-17","modifiedBy":"SBR","dateModified":"2020-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D37F2D20-3AD5-0713-E040-BB89AD437CE5","beginDate":"2013-01-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-01-17","modifiedBy":"ONEDATA","dateModified":"2013-01-17","deletedIndicator":"No"},{"value":"RRM1","valueDescription":"RRM1 Gene","ValueMeaning":{"publicId":"3265643","version":"1","preferredName":"RRM1 Gene","longName":"3265643","preferredDefinition":"This gene plays a role in the inhibition of cell migration, invasion, and metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RRM1 Gene","conceptCode":"C20848","definition":"This gene plays a role in the inhibition of cell migration, invasion, and metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ABE36AD2-3B36-4D30-E040-BB89AD433C58","latestVersionIndicator":"Yes","beginDate":"2011-09-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-01","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D37CA4FD-409B-95E4-E040-BB89AD43110F","beginDate":"2012-05-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-01-17","modifiedBy":"ONEDATA","dateModified":"2013-01-17","deletedIndicator":"No"},{"value":"ERCC1","valueDescription":"Messenger RNA ERCC1 Protein Expression","ValueMeaning":{"publicId":"3467217","version":"1","preferredName":"Messenger RNA ERCC1 Protein Expression","longName":"3467217","preferredDefinition":"A class of RNA molecule containing protein-coding information in its nucleotide sequence that can be translated into the amino acid sequence of a protein.: An immunohistochemical diagnostic test to evaluate the expression of ERCC1 protein at the cellular level.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Messenger RNA","conceptCode":"C813","definition":"A class of RNA molecule containing protein-coding information in its nucleotide sequence that can be translated into the amino acid sequence of a protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"ERCC1 Protein Expression","conceptCode":"C99406","definition":"An immunohistochemical diagnostic test to evaluate the expression of ERCC1 protein at the cellular level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C15A0AFA-45C8-A132-E040-BB89AD435F09","latestVersionIndicator":"Yes","beginDate":"2012-05-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-05-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D37CA4FD-40A5-95E4-E040-BB89AD43110F","beginDate":"2012-05-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-01-17","modifiedBy":"ONEDATA","dateModified":"2013-01-17","deletedIndicator":"No"},{"value":"TS","valueDescription":"Thymidylate Synthase","ValueMeaning":{"publicId":"3467218","version":"1","preferredName":"Thymidylate Synthase","longName":"3467218","preferredDefinition":"Human thymidylate synthetase protein (312 aa, 36 kDa) is encoded by the human (TYMS) gene. The protein is a conserved transferase enzyme that catalyzes methylene tetrahydrofolate (MTHF)/dUMP conversion to dihydrofolate/dTMP in thymidine triphosphate/deoxyribonucleotide biosynthesis. Thymidylate synthetase competes with the methylene tetrahydrofolate receptor for MTHF and maintains the dTMP pool for DNA replication and repair.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thymidylate Synthase","conceptCode":"C17199","definition":"Thymidylate synthetase protein (312 aa, ~36 kDa) is encoded by the human TYMS gene. The protein is a conserved transferase enzyme that catalyzes methylene tetrahydrofolate (MTHF)/dUMP conversion to dihydrofolate/dTMP in thymidine triphosphate/deoxyribonucleotide biosynthesis. Thymidylate synthetase competes with the methylene tetrahydrofolate receptor for MTHF and maintains the dTMP pool for DNA replication and repair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C15A0AFA-45ED-A132-E040-BB89AD435F09","latestVersionIndicator":"Yes","beginDate":"2012-05-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-05-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D37CA4FD-40AF-95E4-E040-BB89AD43110F","beginDate":"2012-05-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-01-17","modifiedBy":"ONEDATA","dateModified":"2013-01-17","deletedIndicator":"No"},{"value":"EML4-ALK fusion arrangement","valueDescription":"EML4-ALK fusion arrangement ","ValueMeaning":{"publicId":"3646276","version":"1","preferredName":"EML4-ALK fusion arrangement ","longName":"3646276","preferredDefinition":"Echinoderm microtubule-associated protein like 4 (981 aa, ~109 kDa) is encoded by the human EML4 gene. This protein may play a role in the modification of microtubule assembly dynamics.: The 2;5 chromosomal translocation is frequently associated with anaplastic large cell lymphomas (ALCLs). The translocation creates a fusion gene consisting of the ALK (anaplastic lymphoma kinase) gene and the nucleophosmin (NPM) gene: the 3' half of ALK, derived from chromosome 2, is fused to the 5' portion of NPM from chromosome 5. A recent study shows that the product of the NPM-ALK fusion gene is oncogenic. The deduced amino acid sequences reveal that ALK is a novel receptor protein-tyrosine kinase having a putative transmembrane domain and an extracellular domain. These sequences are absent in the product of the transforming NPM-ALK gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Echinoderm Microtubule-Associated Protein-Like 4","conceptCode":"C71005","definition":"Echinoderm microtubule-associated protein-like 4 (981 aa, ~109 kDa) is encoded by the human EML4 gene. This protein may play a role in the modification of microtubule assembly dynamics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"ALK Tyrosine Kinase Receptor","conceptCode":"C27032","definition":"ALK tyrosine kinase receptor (1620 aa, ~176 kDa) is encoded by the human ALK gene. This protein is involved in ligand binding, tyrosine phosphorylation and signal transduction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D1399942-0867-FF58-E040-BB89AD4341E1","latestVersionIndicator":"Yes","beginDate":"2012-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-19","modifiedBy":"SBR","dateModified":"2020-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D37CA4FD-40B9-95E4-E040-BB89AD43110F","beginDate":"2012-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-01-17","modifiedBy":"ONEDATA","dateModified":"2013-01-17","deletedIndicator":"No"},{"value":"EGFR TK mutation","valueDescription":"EGFR TK mutation ","ValueMeaning":{"publicId":"3646277","version":"1","preferredName":"EGFR TK mutation ","longName":"3646277","preferredDefinition":"Epidermal growth factor receptor. The protein found on the surface of some cells and to which epidermal growth factor binds, causing the cells to divide. It is found at abnormally high levels on the surface of many types of cancer cells, so these cells may divide excessively in the presence of epidermal growth factor.: Kinases that phosphorylate protein tyrosine residues. These kinases play major roles in mitogenic signalling, and can be divided into two subfamilies: receptor tyrosine kinases, that have an extracellular ligand-binding domain, a single transmembrane domain, and an intracellular tyrosine kinase domain; and nonreceptor tyrosine kinases, which are soluble, cytoplasmic kinases. (Dictionary of Cell and Molecular Biology Online): A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epidermal Growth Factor Receptor","conceptCode":"C17068","definition":"Epidermal growth factor receptor (1210 aa, ~134 kDa) is encoded by the human EGFR gene. This protein plays a role in cell-cell adhesion, cell migration, cell proliferation and signal transduction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Protein Tyrosine Kinase","conceptCode":"C17020","definition":"Kinases that phosphorylate protein tyrosine residues. These kinases play major roles in mitogenic signalling, and can be divided into two subfamilies: receptor tyrosine kinases, that have an extracellular ligand-binding domain, a single transmembrane domain, and an intracellular tyrosine kinase domain; and nonreceptor tyrosine kinases, which are soluble, cytoplasmic kinases. (Dictionary of Cell and Molecular Biology Online)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D1399942-088E-FF58-E040-BB89AD4341E1","latestVersionIndicator":"Yes","beginDate":"2012-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-12-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D37CA4FD-40C3-95E4-E040-BB89AD43110F","beginDate":"2012-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-01-17","modifiedBy":"ONEDATA","dateModified":"2013-01-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3467214","version":"1","preferredName":"Disease Predictive Factor Biomarker Name","preferredDefinition":"Characteristics and conditions that have a bearing on the likelihood of a person developing a disease or disorder.:Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc:The words or language units by which a thing is known.","longName":"C28282:C16342:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Predictive Factor","conceptCode":"C28282","definition":"Characteristics and conditions that have a bearing on the likelihood of a person developing a disease or disorder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C15A0AFA-458C-A132-E040-BB89AD435F09","latestVersionIndicator":"Yes","beginDate":"2012-05-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-05-31","modifiedBy":"ONEDATA","dateModified":"2012-05-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D37CA4FD-4086-95E4-E040-BB89AD43110F","latestVersionIndicator":"Yes","beginDate":"2013-01-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-01-17","modifiedBy":"SBR","dateModified":"2020-09-09","changeDescription":"v2.0 increases the maximum field length from 50 to 80 characters","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812571","version":"1","longName":"Lombardi Cancer Center","context":"NCIP"},{"publicId":"2812605","version":"1","longName":"Lombardi New CDEs","context":"NCIP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104937","version":"1","longName":"RTOG-1306","context":"NRG"}]}],"AlternateNames":[{"name":"PRED_BIOM_NM","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Name of predictive marker","type":"Preferred Question Text","description":"Name of predictive marker","url":null,"context":"NCIP"},{"name":"CRF Text 1","type":"Alternate Question Text","description":"Specify biomarker","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D37CA4FD-4108-95E4-E040-BB89AD43110F","latestVersionIndicator":"Yes","beginDate":"2013-01-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-01-17","modifiedBy":"FORMBUILDER","dateModified":"2014-07-25","changeDescription":"Curated to support Lombardi Cancer Center clinical trial. v2.0 replaces retired v1.0 with an increased field length from 50 to 80 characters. dmr 1/17/2013","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}